Submitted by Anonymous (not verified) on 8 November 2023 - 13:48
Human medicines European public assessment report (EPAR): VidPrevtyn Beta, COVID-19 Vaccine (recombinant, adjuvanted), COVID-19 virus infection, Date of authorisation: 10/11/2022, Revision: 1, Status: Authorised
Source: